FDA Approves Labopharm's Once A Day Antidepressant

The Food and Drug Administration approved Labopharm Inc.'s (Nasdaq: DDSS) once-a-day antidepressant Oleptro Extended Release Tablets. But the stock price dropped 40 cents to close at $2.21.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.